巴西肝病学会肝细胞癌诊断与治疗的最新建议
BRAZILIAN SOCIETY OF HEPATOLOGY UPDATED RECOMMENDATIONS FOR DIAGNOSIS AND TREATMENT OF HEPATOCELLULAR CARCINOMA.
作者信息
Chagas Aline Lopes, Mattos Angelo Alves de, Carrilho Flair José, Bittencourt Paulo Lisboa, Vezozzo Denise Cerqueira Paranaguá, Horvat Natally, Rocha Manoel de Souza, Alves Venâncio Avancini Ferreira, Coral Gabriela Perdomo, Alvares-DA-Silva Mario Reis, Barros Fabio Marinho do Rego, Menezes Marcos Roberto, Monsignore Lucas Moretti, Coelho Fabricio Ferreira, Silva Renato Ferreira da, Silva Rita de Cássia Martins Alves, Boin Ilka de Fatima Santana Ferreira, D Albuquerque Luiz Augusto Carneiro, Garcia José Huygens Parente, Felga Guilherme Eduardo Gonçalves, Moreira Airton Mota, Braghiroli Maria Ignez Freitas Melro, Hoff Paulo Marcelo Gehm, Mello Vivianne Barretto de, Dottori Mariana Fonseca, Branco Tiago Pugliese, Schiavon Leonardo de Lucca, Costa Thaisa de Fátima Almeida
机构信息
Universidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, São Paulo, SP, Brasil.
Universidade de São Paulo, Instituto do Câncer do Estado de São Paulo, São Paulo, SP, Brasil.
出版信息
Arq Gastroenterol. 2020 Mar 9;57(suppl 1):1-20. doi: 10.1590/S0004-2803.202000000-20. eCollection 2020.
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide. The Brazilian Society of Hepatology (SBH) published in 2015 its first recommendations about the management of HCC. Since then, new data have emerged in the literature, prompting the governing board of SBH to sponsor a single-topic meeting in August 2018 in São Paulo. All the invited experts were asked to make a systematic review of the literature reviewing the management of HCC in subjects with cirrhosis. After the meeting, all panelists gathered together for the discussion of the topics and the elaboration of updated recommendations. The text was subsequently submitted for suggestions and approval of all members of the Brazilian Society of Hepatology through its homepage. The present manuscript is the final version of the reviewed manuscript containing the recommendations of SBH.
肝细胞癌（HCC）是全球癌症相关死亡的主要原因之一。巴西肝病学会（SBH）于2015年发布了其关于HCC管理的首份建议。自那时起，文献中出现了新的数据，促使SBH理事会于2018年8月在圣保罗主办了一次单一主题会议。所有受邀专家都被要求对有关肝硬化患者HCC管理的文献进行系统综述。会议结束后，所有小组成员齐聚一堂讨论这些主题，并制定更新后的建议。该文本随后通过巴西肝病学会的主页提交给学会所有成员征求意见并获得批准。本手稿是经过评审的手稿的最终版本，包含了SBH的建议。
Zotero 插件